Japan
Croda Japan was originally formed as a 50:50 partnership of Croda International in 1966, and in 1989 became wholly owned by Croda. One of the pioneering foreign-owned companies to establish its own manufacturing site in Japan, our site in Shiga also developed a process that produces products of extremely high levels of purity, primarily for Personal Care and Health Care. In 2013, it was the second manufacturing site in Japan to be awarded the EFfCI (European Federation for Cosmetic Ingredients) GMP certification and in 2017 was the first in Japan to be awarded the EXCIPACT certificate. Producing a wide range of natural-based specialties from materials such as vegetable oils and lanolins, we also manufacture esters and wax.
The working environment is a good balance of Japanese culture with the dynamism of a global company. Our team enjoys the Croda culture of “safety first, people first”, with employee wellbeing a priority.
Shinjuku Park Tower 11th Floor
3-7-1, Nishi-shinjuku, Shinjuku-ku
Tokyo, Japan 163-1011
Tel: +81(0) 3 6258-1910
Fax: +81(0) 3 5322-2122
Gokasho Hiyoshi-cho
Higashiomi-shi
Shiga, Japan, 529-1403
Tel: +81 (0)748 48 3701
Fax: +81 (0)748 45 5721
The working environment is a good balance of Japanese culture with the dynamism of a global company. Our team enjoys the Croda culture of “safety first, people first”, with employee wellbeing a priority.
Croda Japan KK
Shinjuku Park Tower 11th Floor3-7-1, Nishi-shinjuku, Shinjuku-ku
Tokyo, Japan 163-1011
Tel: +81(0) 3 6258-1910
Fax: +81(0) 3 5322-2122
Shiga Manufacturing Site
Gokasho Hiyoshi-choHigashiomi-shi
Shiga, Japan, 529-1403
Tel: +81 (0)748 48 3701
Fax: +81 (0)748 45 5721
Further reading
11th Most Sustainable International Company
We are celebrating being ranked the top of the chemicals sector for the sixth year running in Britain’s Most Admired Companies award
Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company
Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...
Appointment of Chair Designate
22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.